Birdwatch Note Rating
2023-03-17 02:26:03 UTC - NOT_HELPFUL
Rated by Participant: E967D37E7B60E301EE1E346E3F9508705D550A7BA130F9BD29B956B25B27C3D6
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details